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Background: Chronic respiratory diseases are a significant cause of morbidity and mortality worldwide. We sought
to evaluate the impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations
in daily activities in adults.
Methods: In the Gene Environment Interactions in Respiratory Diseases study (2007/2010), a screening
questionnaire was mailed to 9,739 subjects aged 20–44 (response rate: 53.0%) and to 3,480 subjects aged 45–64
(response rate: 62.3%), who were randomly selected from the general population in Italy. The questionnaire was used
to: identify the responders who had asthma, chronic bronchitis, allergic rhinitis or asthma-like symptoms/dyspnoea/
other nasal problems; evaluate the total burden [use of hospital services (at least one ED visit and/or one hospital
admission) and number of days with reduced activities (lost working days and days with limited, not work related
activities) due to any health problems (apart from accidents and injuries) in the past three months]; evaluate the
contribution of breathing problems to the total burden (hospitalizations and number of days with reduced activities
specifically due to breathing problems).
Results: At any age, the all-cause hospitalization risk was about 6% among the subjects without any respiratory
conditions, it increased to about 9-12% among the individuals with allergic rhinitis or with asthma-like symptoms/
dyspnoea/other nasal problems, and it peaked at about 15-18% among the asthmatics with chronic bronchitis
aged 20–44 and 45–64, respectively. The expected number of days with reduced activities due to any health
problems increased from 1.5 among the subjects with no respiratory conditions in both the age classes, to 6.3 and
4.6 among the asthmatics with chronic bronchitis aged 20–44 and 45–64, respectively. The contribution of
breathing problems to the total burden was the highest among the asthmatics with chronic bronchitis (23-29% of
the hospitalization risk and 39-50% of the days with reduced activities, according to age).
Conclusions: The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations
in daily activities is substantial, and it is markedly different among adults from the general population in Italy. The
contribution of breathing problems to the total burden also varies according to the respiratory condition.
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Table 1 Distribution of the design variables
20-44 yrs 45-64 yrs p-value
N° of eligible subjects* 9739 3480 -
N° of responders
(response rate, %)
5162 (53.0) 2167 (62.3) <0.001
Season at the time
of response, % Spring 46.2 51.5 <0.001
Summer 15.2 8.6
Autumn 32.0 30.9
Winter 6.6 9.0
Telephone interview, % 11.6 9.6 0.012
Females, % 53.6 52.1 0.267
*Eligible = initial sample – (dead or moved away from the target area).
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Asthma, chronic bronchitis and allergic rhinitis are com-
mon health problems in industrialized countries [1-3]
and they often coexist [4-6]. Furthermore, chronic bron-
chitis is associated with both a more severe form of the
disease and poor control of symptoms in subjects with
asthma [7,8], and it may indicate the presence of the
asthma-chronic obstructive pulmonary disease (COPD)
overlap syndrome [9,10].
Asthma generates a high socio-economic burden
among European adults, which significantly increases
when chronic bronchitis is also present [11,12]. More-
over, asthma and allergic rhinitis together account for
most of the allergy-related morbidity associated with the
respiratory system [13]. Therefore, real-world evalua-
tions of the impact of these diseases in the general popu-
lation are fundamental to meet the widespread need for
updated estimates, which should be used as a valid sup-
port to public health decisions.
In recent years, the socio-economic impact of asthma,
chronic bronchitis and allergic rhinitis has been largely
investigated [11,12,14-16]. However, in many studies, the
total burden (i.e. the burden due to any health problems)
in patients with these respiratory illnesses has not been
estimated because only disease-related costs have been
considered. Moreover, the total burden should be com-
pared between patients with a certain disease and un-
affected subjects from the general population. Indeed, a
better understanding of the burden of these respiratory
diseases requires the assessment of their total impact on
the health and social systems.
The aim of the present paper is to compare all-cause hos-
pitalizations and limitations in daily activities among adult
subjects with asthma, chronic bronchitis or allergic rhinitis,
and unaffected individuals from the general population,
and to assess the contribution of breathing problems to the
total burden. To fulfil these purposes, the data from the
screening stage of the Gene Environment Interactions in
Respiratory Diseases (GEIRD) study [17] were used.
Methods
Design of the study
The screening stage of GEIRD was a cross-sectional sur-
vey on respiratory health, which was carried out between
2007 and 2010 in Italy [17]. A total sample of 9,739 sub-
jects aged 20–44 and of 3,480 subjects aged 45–64
(men/women ratio = 1) was randomly selected from the
general population in four centres (Pavia, Sassari, Turin
and Verona) by using the local health authority registers.
A screening questionnaire was mailed to each individual
up to three times and then administered by telephone in
case of nonresponse. Overall, the responders were 5,162
(53.0%) in the 20–44 age group and 2,167 (62.3%) in the
45–64 age group (Table 1).Ethics statement
Ethics approval was obtained in each centre from the ap-
propriate ethics committee (“Comitato di Bioetica della
Fondazione IRCCS Policlinico San Matteo di Pavia”;
“Comitato di Bioetica dell’Azienda Sanitaria Locale di
Sassari”; “Comitato Etico dell’Azienda Sanitaria Locale
TO/2 di Torino”; “Comitato Etico per la Sperimentazione
dell'Azienda Ospedaliera Istituti Ospitalieri di Verona”).
All participants were fully informed about all aspects of
the research project and consented to complete and re-
turn the questionnaire.
Screening questionnaire and definitions
The screening questionnaire (available at www.geird.org) is
a modified version of the questionnaire used in the Italian
Study on Asthma in Young Adults [18]. It contains vali-
dated questions (mainly taken from the European Commu-
nity Respiratory Health Survey questionnaires [19]) on
asthma (self-report of the disease during lifetime with or
without a physician’s diagnosis, frequency of asthma
attacks, and use of anti-asthmatic drugs in the past
12 months), asthma-like symptoms (wheezing, nocturnal
tightness in the chest, and attacks of shortness of breath at
night time in the past 12 months), chronic cough and
phlegm, and nasal problems, as well as questions on occu-
pational status, smoking habits and outdoor air pollution
(frequency of heavy traffic near home and living near in-
dustrial plants).
On the basis of their answers to the questions de-
scribed above, the responders to the screening question-
naire were classified as subjects with:
 asthma (i.e. self-report of the disease during lifetime
with or without a physician’s diagnosis or at least
one asthma attack in the past 12 months or use of
anti-asthmatic drugs in the past 12 months) and
chronic bronchitis (i.e. cough and phlegm on most
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at least two successive years);
 chronic bronchitis without asthma;
 asthma without chronic bronchitis;
 allergic rhinitis (i.e. any nasal allergies, including hay
fever) without asthma and chronic bronchitis;
 asthma-like symptoms or dyspnoea or other nasal
problems without asthma, chronic bronchitis and
allergic rhinitis;
 no respiratory conditions (i.e. none of the conditions
described above).
In addition, the responders were considered exposed to
a high level of outdoor air pollution if they had reported
a continuous passage of trucks near home and/or living
near industrial plants.
The screening questionnaire also includes questions on
the use of hospital services [at least one Emergency Depart-
ment (ED) visit and/or one hospital admission], the number
of lost working days and the number of days with limited,
not work related activities (such as looking after children,
housework or studying) due to any health problems (apart
from accidents and injuries) in the past three months. If
hospital services have been used, the responders should
specify if this has been due to breathing problems. If lost
working days and/or days with limited, not work related ac-
tivities have been reported, the subjects should specify the
number of the impaired days because of breathing problems.
The total burden was evaluated at an individual level on
the basis of the use of hospital services and the number of
days with reduced activities (i.e. the number of lost working
days plus the number of days with limited, not work related
activities) due to any health problems (apart from accidents
and injuries) in the past three months. The days with limited,
not work related activities reported by full-time house-
persons were considered as lost working days. The hospital
services utilization and the number of days with reduced ac-
tivities specifically due to respiratory disorders in the past
three months were used to evaluate the contribution of
breathing problems to the total burden.
Statistical analysis
The cumulative response rate, the season at the time of
response to the questionnaire, the type of contact (postal
waves vs telephone interview), and gender were consid-
ered as potential confounders because of differences in
their distribution between the two age classes (20–44
and 45–64) (Table 1). In particular, the cumulative re-
sponse percentile rank, which is an indicator of the indi-
vidual propensity to respond to the questionnaire, was
used. Each subject was ordered by centre and age class
according to the date of response to the questionnaire,
and then he/she was attributed the ratio between his/her
rank and the number of eligible subjects [20].The prevalence of each respiratory condition was esti-
mated by using a logistic model, which included age class,
centre and the potential confounders reported above, as
covariates. The all-cause hospitalization risk [i.e. the pro-
portion of subjects with at least one ED visit and/or one
hospital admission due to any health problems (apart from
accidents and injuries) in the past three months] and the
expected number of days with reduced activities due to
any health problems in the same period were estimated by
using logistic and negative binomial models [21], respect-
ively, which included the respiratory condition crossed by
the age class, centre and the potential confounders re-
ported above, as covariates. Since the subjects were nested
into centres, clustered sandwich estimators of the variance
were used. The estimates were computed in each age class
and for each respiratory condition by setting the distribu-
tion of gender, season at the time of response to the ques-
tionnaire, type of contact and centre equal to the average
distribution, and by setting the cumulative response rate
equal to the overall mean [22].
A multivariable analysis was carried out to evaluate the
association of each component of the total burden (i.e. all-
cause hospitalizations and limitations in daily activities)
with the respiratory condition, gender, occupational status,
smoking habits and a high level of outdoor air pollution.
Logistic and negative binomial models were computed
separately in each age class and the estimates were ad-
justed for centre and the potential confounders reported
above. Clustered sandwich estimators of the variance were
used. The results of the negative binomial models were
summarized as mutually adjusted Ratios of Expected
Number of Days with reduced activities (RENDs).
In each age class and for each respiratory condition,
the percentage contribution of breathing problems to
all-cause hospitalizations and limitations in daily activ-
ities in the past three months was obtained by dividing
the hospitalization risk and the expected number of days
with reduced activities specifically due to respiratory dis-
orders, by the corresponding component of the total
burden. All the estimates of the hospitalization risk and
of the expected number of days with reduced activities
were adjusted for centre and the potential confounders
reported above. Ninety-five percent confidence intervals
(95%CIs) were computed by using the bias-corrected
bootstrap method [23] with 2,000 replications.
The statistical analysis was performed by using STATA
software, release 13 (StataCorp, College Station, TX).
Results
All-cause hospitalizations and limitations in daily
activities according to the respiratory condition
The percentage of subjects who reported any respiratory
condition was 57.7% (95%CI: 57.4 to 58.0%) in the 20–44
age class and 54.8% (95%CI: 54.0 to 55.6%) in the 45–64
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cording to age (Figure 1).
The risk of having at least one ED visit and/or one hos-
pital admission due to any health problems (apart from ac-
cidents and injuries) in the past three months was 8.8%
(95%CI: 8.3 to 9.3%) and 9.5% (95%CI: 8.1 to 11.0%)
among the subjects aged 20–44 and 45–64, respectively.
At any age, the risk of all-cause hospitalization was about
6% among the subjects with no respiratory conditions, it
increased to about 9-12% among the individuals reporting
allergic rhinitis or asthma-like symptoms/dyspnoea/other
nasal problems, and it peaked at about 15-18% among the
asthmatics with chronic bronchitis aged 20–44 and 45–
64, respectively (Figure 2). The same trend was observed
after adjusting for the effect of the other potential determi-
nants: the odds ratio (OR; reference category: no respira-
tory conditions) ranged from 1.62 to 2.36 in the 20–44 age
class and from 2.09 to 4.24 in the 45–64 year-old group,
respectively (Table 2).
The expected number of days with reduced activities
due to any health problems (apart from accidents and
injuries) in the past three months was 2.4 (95%CI: 2.3 to
2.5) and 2.3 (95%CI: 2.1 to 2.5) among the subjects aged
20–44 and 45–64, respectively. This estimate increased
from 1.5 days among the individuals with no respiratory
conditions in both the age classes, to 6.3 and 4.6 days
among the asthmatics with chronic bronchitis aged 20–
44 and 45–64, respectively (Figure 2). The subjects aged
45–64 with asthma-like symptoms/dyspnoea/other nasal
problems were characterised by a particularly high figure
(3.2 days). The increasing trend in the number of days
with reduced activities was confirmed after adjusting for
the effect of the other potential determinants: the REND%
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Figure 1 Prevalence* of each respiratory condition. Bars represent
95% confidence intervals. *The estimates were adjusted for the
cumulative response rate, the season at the time of response to the
questionnaire, the type of contact, gender and centre.(reference category: no respiratory conditions) ranged
from 1.64 to 3.87 in the 20–44 age class and from 2.05 to
4.33 in the 45–64 year-old group, respectively (Table 3).Contribution of breathing problems to all-cause
hospitalizations and limitations in daily activities
Breathing problems accounted for less than 50% of all-
cause hospitalizations and limitations in daily activities,
and the percentage contribution of breathing problems to
the total burden varied according to the respiratory condi-
tion in both the age classes (Figure 3). In particular, the
highest contribution of breathing problems to the total
burden was observed among the asthmatics with chronic
bronchitis (23-29% of the hospitalization risk and 39-50%
of the days with reduced activities, according to age),
whereas the lowest figure was observed among the indi-
viduals with asthma-like symptoms/dyspnoea/other nasal
problems (4-5% of the hospitalization risk and 10-11% of
the days with reduced activities, in the two age groups).Other determinants of all-cause hospitalizations and
limitations in daily activities
According to the multivariable analysis, females showed
an increased hospitalization risk (OR: 1.46) and an in-
creased number of days with reduced activities (REND:
1.73) in the population aged 20–44, whereas they had
less hospitalizations (OR: 0.70) in the population aged
45–64, as compared to males in the same age class
(Tables 2 and 3). As compared to white collars/house-
persons/students of the same age, unemployed/retired
subjects had an increased hospitalization risk in both the
age classes (OR: 1.60 and 1.39, respectively), as found for
blue collars (OR: 1.31) in the 20–44 age class; moreover,
blue collars showed heavier limitations in daily activities in
both the age groups (REND: 1.73 and 2.17, respectively).
As compared to never smokers aged 45–64, past smokers
had an increased hospitalization risk (OR: 1.20) and an in-
creased number of days with reduced activities (REND:
1.80), whereas current smokers showed lesser limitations
in daily activities (REND: 0.66). In the same age class, the
individuals reporting a high level of outdoor air pollution
showed an increased hospitalization risk (OR: 1.47), as
compared to the subjects reporting a low exposure.Sensitivity analyses
The stability of the results was evaluated by repeating
the analysis also adjusting for smoking habits or without
adjusting for the cumulative response rate, the season at
the time of response to the questionnaire and the type
of contact. The estimates obtained under these two con-
ditions were comparable with the figures computed in
the main analysis (data not shown).
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Figure 2 All-cause hospitalizations and limitations in daily
activities in the past three months*. Bars represent 95%
confidence intervals. *The all-cause hospitalization risk is the proportion
of subjects with at least one ED visit and/or one hospital admission
due to any health problems (apart from accidents and injuries) in the
past three months; the estimates were adjusted for the cumulative
response rate, the season at the time of response to the questionnaire,
the type of contact, gender and centre.
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The main results of the present study are the following:
 the subjects with asthma, chronic bronchitis or
allergic rhinitis have a two- to four-fold increased
risk of all-cause hospitalizations and limitations in
daily activities, as compared to unaffected individuals
from the general population;
 among the subjects with asthma, chronic
bronchitis or allergic rhinitis, breathing problems
account for less than 50% of all-cause hospitaliza-
tions and limitations in daily activities, and the
contribution of breathing problems to the total
burden varies according to the respiratory
condition;
 female gender, a low occupational status and a high
level of outdoor air pollution contribute to the
total burden.The presence of asthma, chronic bronchitis or allergic
rhinitis is associated with an increase in all-cause
hospitalizations and limitations in daily activities
Our data show that the risk of hospitalization and the
number of days with impaired activities due to any
health problems (apart from accidents and injuries) are
impressively higher among adults with asthma, chronic
bronchitis or allergic rhinitis, as compared to unaffected
individuals from the general population in Italy. This re-
sult is in agreement with the findings in other studies,
which show that respiratory symptoms are among the
major causes of consultation at primary health care cen-
tres in different countries [24], and that these diseases
impair work performance, social life and physical quality
of life [25-27].
In each age class, the heaviest burden is associated
with the coexistence of asthma and chronic bronchitis.
In particular, the risk of all-cause hospitalization peaks
among the 45–64 year-old subjects with both these con-
ditions, whereas this risk is not so much higher than the
figures observed among the individuals with the other re-
spiratory conditions in the 20–44 age class. A possible ex-
planation for this could be that the presence of chronic
bronchitis may be an early expression of COPD in the
older age group [28], whereas it may be an expression of
post nasal drip among the individuals aged 20–44 [29].
Among the 45–64 year-old subjects, those reporting
asthma-like symptoms/dyspnoea/other nasal problems
show a heavy burden. This result could be explained by
the age-related increase in the incidence of pneumonia,
lung cancer, COPD or other diseases that cause dys-
pnoea or respiratory symptoms, which often require ED
visits or hospital admissions.
The contribution of breathing problems to all-cause
hospitalizations and limitations in daily activities varies
according to the respiratory condition
In our study, breathing problems account for less than 50%
of all-cause hospitalizations and limitations in daily activ-
ities. This is not surprising because Druss and colleagues
[30] reported that about one fourth of the costs due to five
chronic conditions (mood disorders, diabetes, heart disease,
asthma and hypertension) in the United States were in-
curred in treating the conditions themselves, whereas the
remaining costs were due to coexisting illnesses.
The contribution of breathing problems to the total bur-
den varies according to the respiratory condition, even if
the results pertaining to the 45–64 age class should be
interpreted with caution because of the large confidence
intervals, which is due to the smaller sample size of that
group, as compared with the dimension of the 20–44 age
class. In particular, the highest weight of breathing prob-
lems is found among the subjects with coexisting asthma
and chronic bronchitis, which suggests that the burden for
Table 2 Potential determinants of all-cause hospitalizations in the past three months
20-44 yrs 45-64 yrs
OR* [95% CI] p-value OR* [95% CI] p-value
Respiratory condition No respiratory conditions 1.00 - 1.00 -
Asthma-like symptoms/dyspnoea/other nasal problems 1.62 [1.15 to 2.28] 0.005 2.09 [1.65 to 2.65] <0.001
Allergic rhinitis without asthma and chronic bronchitis 1.73 [1.09 to 2.73] 0.019 1.79 [1.07 to 2.98] 0.027
Asthma without chronic bronchitis 2.08 [1.84 to 2.35] <0.001 2.09 [1.32 to 3.32] 0.002
Chronic bronchitis without asthma 1.85 [1.44 to 2.39] <0.001 3.38 [1.95 to 5.88] <0.001
Asthma and chronic bronchitis 2.36 [1.45 to 3.84] 0.001 4.24 [2.06 to 8.70] <0.001
Gender Male 1.00 - 1.00 -
Female 1.46 [1.04 to 2.07] 0.030 0.70 [0.53 to 0.91] 0.008
Occupational status White collar/house-person/student 1.00 - 1.00 -
Blue collar 1.31 [1.05 to 1.63] 0.016 0.74 [0.43 to 1.28] 0.278
Unemployed/retired subject 1.60 [1.03 to 2.50] 0.038 1.39 [1.00 to 1.93] 0.049
Smoking habits Never smoking 1.00 - 1.00 -
Past smoking 1.22 [0.87 to 1.70] 0.252 1.20 [1.08 to 1.33] 0.001
Current smoking 1.45 [0.96 to 2.18] 0.076 0.97 [0.62 to 1.53] 0.892
High level of outdoor air pollution Absent 1.00 - 1.00 -
Present 1.05 [0.81 to 1.37] 0.708 1.47 [1.18 to 1.84] 0.001
*Mutually adjusted odds ratios (ORs) of hospital services utilization (at least one ED visit and/or one hospital admission) due to any health problems (apart from
accidents and injuries) in the past three months; the ORs were also adjusted for the cumulative response rate, the season at the time of response to the
questionnaire, the type of contact and centre.
Table 3 Potential determinants of all-cause limitations in daily activities in the past three months
20-44 yrs 45-64 yrs
REND* [95% CI] p-value REND* [95% CI] p-value
Respiratory condition No respiratory conditions 1.00 - 1.00 -
Asthma-like symptoms/dyspnoea/other nasal problems 1.64 [1.23 to 2.18] 0.001 2.05 [0.85 to 4.97] 0.112
Allergic rhinitis without asthma and chronic bronchitis 1.72 [1.37 to 2.17] <0.001 1.46 [0.64 to 3.31] 0.366
Asthma without chronic bronchitis 1.76 [1.33 to 2.32] <0.001 2.15 [1.43 to 3.22] <0.001
Chronic bronchitis without asthma 2.42 [1.90 to 3.08] <0.001 3.19 [2.22 to 4.59] <0.001
Asthma and chronic bronchitis 3.87 [2.99 to 5.03] <0.001 4.33 [2.10 to 8.89] <0.001
Gender Male 1.00 - 1.00 -
Female 1.73 [1.37 to 2.18] <0.001 0.95 [0.84 to 1.08] 0.436
Occupational status White collar/house-person/student 1.00 - 1.00 -
Blue collar 1.73 [1.57 to 1.91] <0.001 2.17 [1.06 to 4.47] 0.035
Unemployed/retired subject† - - - -
Smoking habits Never smoking 1.00 - 1.00 -
Past smoking 1.17 [0.97 to 1.40] 0.093 1.80 [1.22 to 2.66] 0.003
Current smoking 1.07 [0.93 to 1.23] 0.324 0.66 [0.53 to 0.82] <0.001
High level of outdoor air pollution Absent 1.00 - 1.00 -
Present 1.17 [0.88 to 1.55] 0.288 1.54 [0.94 to 2.54] 0.087
*Mutually adjusted ratios of expected number of days with reduced activities (RENDs) due to any health problems (apart from accidents and injuries) in the past
three months; the RENDs were also adjusted for the cumulative response rate, the season at the time of response to the questionnaire, the type of contact and
centre. †The RENDs are not reported because unemployed/retired subjects have no lost working days.
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Figure 3 Percentage contribution of breathing problems to all-cause hospitalizations and limitations in daily activities in the past three
months*. Bars represent 95% confidence intervals. *The all-cause hospitalization risk is the proportion of subjects with at least one ED visit and/or
one hospital admission due to any health problems (apart from accidents and injuries) in the past three months; the estimates were adjusted for
the cumulative response rate, the season at the time of response to the questionnaire, the type of contact, gender and centre.
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indirectly confirms that chronic bronchitis is associated
with both a more severe form of the disease and poor con-
trol of symptoms in asthmatic subjects [7,8], or it may be
an expression of the coexistence of asthma and COPD
[9,10]. Accordingly, poor control of symptoms and coex-
isting chronic bronchitis were both associated with in-
creased disease-related costs in European adults with
asthma [12]. On the contrary, the contribution of breath-
ing problems is particularly low among the subjects with
allergic rhinitis only, whereas it is at an intermediate level
among those with asthma or chronic bronchitis only,
which suggests a progressive increase in the level of im-
pairment due to these respiratory diseases.
Breathing problems have the lowest weight in determin-
ing all-cause hospitalizations and limitations in daily activ-
ities for the subjects with asthma-like symptoms/dyspnoea/
other nasal problems. Different factors may contribute to
explain this finding. Smoking is associated with respiratory
symptoms and it is strongly associated with cardiac and
cerebrovascular diseases, and with diabetic complications.
Dyspnoea and non-specific respiratory symptoms may be
attributable to other illnesses, such as heart failure,essential hypertension, anaemia, electrolyte disorders or
gastroesophageal reflux. Moreover, in the case of comor-
bidities such as diabetes, anaemia, hypertension or tachy-
cardia, the decision to admit a patient can be based not
only on factors that are directly related to the respiratory
disease, but also on the difficulty in managing an out-
patient. In fact, these patients are likely to require more
health services and more complex health management
strategies.
Other determinants of all-cause hospitalizations and
limitations in daily activities
Females aged 20–44 report a heavier burden as compared
to males in the same age class, regardless of their disease
status. In fact, females are probably more concerned about
their health than males [31], as previously found among
young adults with asthma in Italy [32]. On the contrary,
the risk of all-cause hospitalization is lower among females
aged 45–64, in accordance with official Italian statistics for
the same period [33]. A heavier burden is reported by sub-
jects with a low occupational status (i.e. blue collars and
unemployed/retired individuals), in accordance with previ-
ous results for adult asthma in Italy [32]. This could be
Accordini et al. BMC Pulmonary Medicine  (2015) 15:10 Page 8 of 9due to factors that affect health and are more frequent in
lower social classes, such as residential and workplace pol-
lutant exposures [34], or it could reflect a cumulative life
course disadvantage [35]. Self-reported high levels of out-
door air pollution are associated with an increased risk of
all-cause hospitalization among the subjects aged 45–64,
which suggests that the exposure to air pollution has a
long-term effect on health [36,37]. Finally, the pattern of
association between smoking habits and the total burden
could be due to the “healthy smoker effect” bias, since the
subjects with the most severe underlying disease are the
least likely to smoke [38].
Strengths and weaknesses of the study
The main strength of the present analysis is that the data
were collected through a highly standardized protocol
[17], which ensures the comparability of the information
among the centres. Moreover, the prevalence rates are
based on self-reported symptoms, which were measured
through an international validated questionnaire [18],
and are less influenced by diagnostic procedures. In
addition, the data were collected from patients who had
been identified in the general population, rather than
from clinically selected groups, which should guarantee
that the studied sample encompasses a wide spectrum of
respiratory conditions. Finally, a potential measurement
error [39] could have influenced our estimates of the
burden only to a minor extent, because our study did
not involve elderly patients and the recall period consid-
ered in the questionnaire (three months) was short.
A few caveats should be taken into account when
interpreting our results. Only four centres participating
in GEIRD collected the information on the subjects aged
45–64 and so there could be a potential limitation in the
generalizability of the results. Moreover, the participa-
tion rate was quite low (53.0%) among young adults, as
observed in other epidemiological studies over the past
decades [40], and this may have biased our estimates for
this age class. However, it has been suggested that de-
creasing participation rates are not likely to have a sub-
stantial influence on the point estimates of measures of
interest [40]. Finally, it was not possible to directly
evaluate the impact of comorbidities on the total bur-
den because questions on coexisting diseases had not
been included in the screening questionnaire, in order
to minimize its length and therefore increase the re-
sponse rate [18]. In addition, the screening question-
naire does not allow to compute separate estimates of
the risk of having at least one ED visit and of the risk
of having at least one hospital admission in the past
three months. Therefore, the possible overestimation
of hospital services utilization cannot be detected
through the comparison with ED visit rates and hos-
pital in-patient admission rates from other sources.However, participation bias could have inflated our es-
timates of the hospitalization risk to some extent.
Conclusions
The impact of asthma, chronic bronchitis and allergic rhin-
itis on all-cause hospitalizations and limitations in daily ac-
tivities is substantial, and it is markedly different among
adult subjects from the general population in Italy. The
contribution of breathing problems to the total burden also
varies according to the respiratory condition. Gender, occu-
pational status and outdoor air pollution contribute to the
total burden.
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